Prosight Management, LP - NOVELION THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 37 filers reported holding NOVELION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Prosight Management, LP ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,314,000
+83.5%
444,068
+128.1%
0.73%
+39.6%
Q2 2018$716,000
-12.3%
194,663
-16.5%
0.52%
+2.5%
Q1 2018$816,000
-11.8%
233,003
-21.4%
0.51%
-24.7%
Q4 2017$925,000–296,488–0.68%–
 Download
Other shareholders

There were no reported owners of NOVELION THERAPEUTICS INC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of NOVELION THERAPEUTICS INC shareholders